Rare disease investigators constantly face challenges in identifying additional cases to build evidence for gene-disease causality. The Matchmaker Exchange (MME) addresses this limitation by providing a mechanism for matching patients across genomic centers via a federated network.
INTRODUCTION
The Matchmaker Exchange (MME) (Philippakis et al., 2015) , launched in 2013 and reliant on standards defined within the Global Alliance for Genomics and Health, allows investigators searching for novel genetic causes of rare disease to find individual patients with the same candidate gene and overlapping phenotypic features. MME, made up of nine nodes located in five countries and supporting users from over 73 countries, mitigates the challenge of data ownership and international regulatory limitations regarding movement Human Mutation. 2018;39:1827-1834.
c 2018 Wiley Periodicals, Inc. 1827 wileyonlinelibrary.com/journal/humu of data across country boundaries, and provides more site control of sharing preferences and matching algorithms by utilizing an application programming interface (API) that allows local hosting of data.
Patient data shared through the MME are anonymized and no protected health information (PHI) is shared. Once a match happens between two participant genomic centers, the two "data-owners" of the patients are put into contact with each other to evaluate the validity of the match. There are two routes by which new candidate genes can be submitted into the network: addition by existing nodes or launch of a new node onto the federated network. matchbox (https://github.com/macarthur-lab/matchbox), a software solution designed to be easily installed in any number of centers worldwide, facilitates the latter route.
When MME was launched, a center (node) interested in joining the MME had to build the software functionality-either from scratch or off of an illustrative open source reference implementation (https:// github.com/MatchmakerExchange/reference-server) not intended for a production setting. While there were a few other open source implementations (https://github.com/ga4gh/mme-apis/wiki/ Implementations), these were coupled to their host institution infrastructure and purpose. To enable faster growth of the MME network, we launched matchbox to reduce technology as a barrier to launching a new node and thereby provide matchmaking capabilities to many more patients of diverse origins worldwide. While matchbox and seqr have been previously introduced as part of a protocol for MME use (Sobreira et al., 2017) , we now provide more detail on the design, implementation, and usage of these applications, highlighting their abilities to improve the process of novel gene discovery.
RATIONALE FOR BUILDING MATCHBOX
Understanding and building a matchmaker server can be challenging, consuming both time and resources. matchbox is a ready-built, scalable, easy-to-use, minimal but robust solution for aiding the launch of a new rare disease center as part of the MME federated network. Although matchbox reduces the barriers to entry through the provision of consistent basic infrastructure for matching, the host is still able to improve or change matching algorithms as they deem fit. matchbox can handle communication between matchmaker centers and act as a repository that is isolated from a center's general patient database, containing only cases whose attributes are allowed to be shared within the network. Currently, it takes about 30 minutes to download, setup, and start an instance on a Unix-like system. matchbox is intended for an institution supporting many end-users and with software development capabilities and informatics resources sufficient to host and start a server in a Unix environment. Such institutions tend to have an existing database for storing local patient data from its local users and are looking for a means of connecting that application to the MME, but have limited engineering resources to build such a bridge, or would prefer to use an existing solution. However, for those also lacking an existing database, we propose the seqr application (https://github.com/macarthur-lab/seqr), a companion freely available open source analysis platform that can be easily integrated with matchbox (described later in the manuscript).
As of now, matchbox is not designed for a single individual user, though it is quite possible for a single user familiar with Unix environments to start and maintain a matchbox instance. matchbox implements the Matchmaker Exchange API specification (Buske et al., 2015) , whereby a new node joining the MME has the option of using matchbox versus the resource-intensive route of building their own software.
Given matchbox's freely available open-source nature, we encourage the community to join in to maintain, augment, and build on this application so that it will lead to continuous improvement and further collaborative open science approaches to rare disease diagnosis.
MATCHBOX ARCHITECTURE
matchbox is built using Java 1.8 (Oracle Corporation, Redwood Shores, CA) and the Spring boot (https://projects.spring.io/spring-boot/) framework (Pivotal Software, San Francisco, CA). It currently uses MongoDB (https://www.mongodb.com/) as the primary database.
matchbox has the following endpoints (see Table 1 ). Patient data in matchbox were collected under a Partners Healthcare IRB-approved protocol.
MATCHBOX MATCHING ALGORITHM
The heart of matchbox is its matching algorithm that it uses to determine whether two distinct patients are similar to each other. Similarity is quantified to guide prioritization of matches. As per MME API specification, each result pair must provide an enumeration between 0 and 1 that represents the similarity strength and each host institution determines the algorithm used for matching. matchbox separately scores on genotype and phenotype similarity, followed by the merging of these into a single overall similarity score between 0 and 1 that we return with the result as specified by the MME API. We also return the individual genotype and phenotype scores that contributed to the merged score for transparency and data richness.
The extent of similarity of each result pair is quantified by: when genotype score ≠ 0 and phenotype score ≠ 0 ⇒ result score = genotype score × phenotype score It must be highlighted that the MME operates in an imperfect universe with varying amounts of data shared per patient query. A great part of the success of MME has been its capability to be flexible and allow queries to contribute as much data as possible above a bare minimum, such as simply gene names and or phenotypes. While it is understood that the strength of the result is largely contingent upon how descriptive the query is, the algorithm must be able to function at both ends of the data-sharing spectrum. To allow for this spectrum of information availability, we have added in pivots that prevent the system from refusing queries and adjust itself as appropriate to data provided. 
TA B L E 1 ALL POST methods and the DELETE method expect a JSON data structure

THE GENOTYPE SCORING STRATEGY
When genotype data are provided, they are used as the primary matching criteria, with phenotype data used in scoring to further rank the genotype matches. matchbox does have the capability to match only on phenotypes in the absence of genotype or when the given genotypes result in no matches. The host center can decide whether or not to utilize this latter feature as phenotype-only matching may not be universally desired. We have observed that default inclusion of matching only on phenotypes is often undesirable by users given the level of false positives that it generates; we believe this will improve over time with better phenotyping.
Our base criterion for a match is two patients containing the same candidate gene, with or without defined variant(s). The similarity of genotypes is calculated using constraint scores, population frequencies via gnomAD (https://gnomad.broadinstitute.org) and the patient population within matchbox. To optimize performance of this calculation and minimize network travel, we cache gnomAD metrics.
As the first step of our matching process, the candidate gene ± specific variant(s) for each patient in matchbox are compared pairwise with the query patient. When genes in common are noted, a baseline metric is generated with the help of gnomAD exome data. If a specific variant is provided, it is used to fetch the exome allele frequency from the gnomAD API (https://gnomad-api.broadinstitute.org). For example, we use the start and stop positions, chromosome, alternate and reference bases using a query similar to,
We then calculate the inverse of this allele frequency. The idea behind this inversion is that if a variant is present at an appreciable allele frequency in a normal population (a population depleted of severe, pediatric-onset disease), it is less likely to be disease causing. If a patient has more than one candidate gene specified, we use their score product. Currently there are no means of weighing candidate genes based on importance; hence we assume each has equal importance in disease; we do plan to introduce weights in the future as discussed later.
gnomad score = score of gene candidate 1 × score of gene candidate 2 … .
The resulting gnomAD based score is then scaled to between 1 and 0 using the logistic function and is used as the baseline genotype score.
Once all patients in matchbox that satisfy this minimum criteria of having a candidate gene in common are identified and a baseline score is calculated, we further augment this score by calculating the preva- 
matchbox integration with seqr
matchbox was built as a backend server that facilitates communication with the MME and does not have a native graphical user interface. We use the seqr Web application for this purpose (https://seqr.
broadinstitute.org/)
. seqr is the analytical platform for the Cen- seqr groups data into projects, families, and individuals. Typically an individual is visible to everyone who has access to the project to which the individual belongs. One or more projects originate from a collaborator. A project team typically consists of a collaborator and a lead analyst from the Broad CMG. At the time of writing, to add a patient to the MME via matchbox an investigator has to become a collaborator with the Broad's CMG and add their data to seqr.
The general workflow as it relates to seqr at the Broad's CMG involves gathering variant and pedigree information from collaborators and uploading them to seqr, followed by collaborative analysis.
Variant information is obtained via raw VCF files that are parsed using the Hail (https://github.com/hail-is/hail) framework and inserted into a ElasticSearch (https://www.elastic.co/products/elasticsearch) database cluster. The seqr Web application uses this distributed database as a variant store along with an instance of a Postgresql database (https://www.postgresql.org) to store operational data such as usernames, project structures and other tables required by the applied Django framework (https://www.djangoproject.com).
Having seqr be the frontend to matchbox has quite a few benefits.
First, it functions as a user interface and provides a one-click process to share patient information with the MME. seqr fully centralizes and integrates all information that aids in moving a patient toward a genetic diagnosis. Another benefit of being embedded and proxied through seqr is that matchbox is not exposed directly to the internet. For an extra layer of security, only a single port is exposed to allow access from seqr. seqr and matchbox are distinct entities and only data from a subset of the over 17,000 patients in seqr are submitted to MME. Patients for whom causal candidate genes are identified and the data owner's permission is gained are inserted into matchbox.
The family page is the workhorse of the seqr system and gives the ability to centralize phenotypes, genotypes, clinician analyst notes, tag variants, and at one glance give a summary of progress on a patient or family. We have embedded the PhenoTips (Girdea et al., 2013 ) application within seqr to help gather phenotype data efficiently (Figure 1 ). Once the project team determines a causal candidate gene, they can easily share it in the MME, along with phenotype information via matchbox. After the genotype and/or phenotype information is inserted into matchbox, it is visible to, and automatically searched within, the MME. Search results are summarized in the family page and updated at every visit. For a detailed view and record keeping functions, or to update their submission, users can visit the detailed search page (Figures 2 and 3 ).
Once shared, match information can be viewed via the seqr family page. Analysts can easily identify any new matches that have arisen since their last visit. Two types of matching can be described: "passive matching" that happens once data is shared in matchbox and the submitter is contacted by an external party, who is now able match against the submission, or "proactive", whereby seqr-user views matches and reaches out to the other party. We monitor incoming contacts from such "passive" matches for prompt response and support; automated alerts also serve as notification of searches being performed and matches made.
Downloading the source code and starting an instance
We encourage usage and modification of the matchbox code as needed and firmly believe that it must be a community driven application. 
matchbox UTILIZATION
At the time of writing, matchbox carried 257 patients contributing 292 unique candidate genes and 537 unique HPO terms. This is fewer than the number of cases contained in nodes that have been in operation longer such as GeneMatcher or DECIPHER (Firth et al., 2009) but we hope this approach allows more nodes to join emphasizing federation as a key approach to data sharing. matchbox receives about 100 match requests a week and continues to grow with our Center's gene discovery efforts. A subset of these is matched with patients within the matchbox system. These matched patients are then investigated by the project team and data owners of the external patient of the match are contacted for more information and possible collaborations. It must be noted that, consistent with historical practice, only a small subset of these moves on to a full collaboration status. Although this is primarily due to candidate genes being entered with limited evidence, additional factors include some of the systematic weakness prevalent in the network, such as non-perfect matching algorithms and minimal input data resulting in imperfect matching.
DISCUSSION
matchbox has been instrumental to the novel gene discovery initiative at the Broad CMG. Due to its integration with seqr, our exome and genome analysis interface, novel disease gene candidates that are identified by our analysts are easily entered into the MME using this platform. To date, matches made via matchbox have led to three scientific publications (Guissart et al., 2018; Hamdan et al., 2017; Yates et al., 2017) and one additional manuscript has recently been submitted for publication. Five additional publications are in preparation and at least nine additional genes in active discussion.
The organic growth of the MME in support of matching patients has led to many strengths and flexibilities, but has introduced some inherent challenges to scalability and functionality in its architecture. While the diversity of matching algorithms has allowed exploration of new innovative ideas, it has created some weaknesses; primary among them is the lack of reproducibility of the enumeration of match strength that is generated by the host using its internal algorithms and data. This has made match strength comparison across different centers impossible.
F I G U R E 2
Family page that summarizes results from MME search (using test data for exhibition)
If instead, most new sites implement the same system, such as matchbox, this diversity will lessen and improve the comparability of results over time. Although this approach does decrease innovation, through ongoing collaboration of a technical working group that supports the MME we continue to work toward improving the tools, algorithms and functions of the MME to ensure continued innovation while working to minimize unnecessary differences.
Developing and supporting the software to join the MME can also be quite intensive and we believe that this has had a detrimental effect on network growth. At its core, the benefits of the MME hinge greatly on the number of patients it contains. Hence, it is crucial that we facilitate continuous growth and add as many patients and nodes into the network as possible. By providing a ready-made, open-source application that can be used almost immediately, new nodes have a stronger incentive to use this tool versus building their own and thus saving the often limited software development resources across sites.
Additionally, we foresee matchbox as a platform that will allow the plugin of various features as micro-services as it matures F I G U R E 3 Detailed MME search result page (using test data for exhibition) allowing continued improvement in the functions of the MME platform.
We see an ecosystem of micro-services that can be started up on host premises that would provide post-processing capabilities as needed, and incrementally address some of the challenges in quality control such as ensuring a sufficient amount of data to be entered to enable more specific matching. We plan to encourage the community to build these with us and by themselves as needed. In the future, we hope nodes that wish to develop their own matching algorithms would use such microservices to filter or rank matchbox results further on their new rule-sets. Microservices are also a means of integrating in technologies such as PhenoPackets (https://phenopackets.org/) for data exchange and extending the interpretive capabilities of matchbox.
One possible architecture could be a microservice functioning downstream of matchbox augmenting or filtering the results further before returning them to the querier. In the future, we do intend to provide a nginx-based alternative (https://www.nginx.com/) that would function as a proxy for the public API endpoints and hide the sensitive endpoints. We are also considering bundling in a lightweight Website as an alternative to the seqr for users that require only MME functionality.
We plan to work with the community to build this.
CONCLUSIONS
We have presented matchbox as an open-source tool to facilitate entry into the MME. While this application will continue to evolve, we believe that it represents an important contribution to ongoing novel gene discovery initiatives, by further bringing together rare disease patients from around the world for the benefit of patient care and scientific innovation.
